Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09IOF
|
||||
Former ID |
DIB013489
|
||||
Drug Name |
Troplasminogen alfa
|
||||
Synonyms |
TAPgen; BB-10153; Thrombin activatable plasminogen, British Biotech; Thrombin activatable plasminogen, Vernalis; V-10153
|
||||
Indication | Myocardial infarction [ICD9: 410; ICD10:I21, I22] | Phase 2 | [521672] | ||
Company |
Vernalis
|
||||
Target and Pathway | |||||
Target(s) | Plasminogen | Target Info | Modulator | [527763], [532368] | |
PANTHER Pathway | Blood coagulation | ||||
Plasminogen activating cascade | |||||
PathWhiz Pathway | Coagulation | ||||
WikiPathways | Complement and Coagulation Cascades | ||||
Human Complement System | |||||
Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
Activation of Matrix Metalloproteinases | |||||
Blood Clotting Cascade | |||||
Dissolution of Fibrin Clot | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.